cystic-fibrosis

Documents about cystic-fibrosis

• Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)#868567ClinicalTrials.gov
• Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes#346859ClinicalTrials.gov
• Reproductive Futures in Focus: Contraceptive Choices Among Individuals With Cystic Fibrosis-Patterns, Preferences, and Influencing Factors.#684055eScholarship
• A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1#834643ClinicalTrials.gov
• A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects#835863ClinicalTrials.gov
• Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis#883582ClinicalTrials.gov
• A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida#897696ClinicalTrials.gov
• Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis#967212ClinicalTrials.gov
• The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis.#876851ClinicalTrials.gov
• Evaluation of an Airway Clearance System#832056ClinicalTrials.gov
• Tissue Bank for Pulmonary Diseases#834303ClinicalTrials.gov
• Efficacy of Nasal Irrigation With Respimer® Netiflow® vs Saline Among Patients With Cystic Fibrosis and Chronic Rhinosinusitis#801209ClinicalTrials.gov
• A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del#825585ClinicalTrials.gov
• Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis#865267ClinicalTrials.gov
• A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients#887048ClinicalTrials.gov
• A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes#978904ClinicalTrials.gov
• Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis: The Home-Reported Outcomes in Cystic Fibrosis 2 Study Design.#427971NCBI PubMed Central
• Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis#894953ClinicalTrials.gov
• Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis#916838ClinicalTrials.gov
• Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)#407749ClinicalTrials.gov
• Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis#444897ClinicalTrials.gov
• Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics#801112ClinicalTrials.gov
• Structure and Function of Salivary Proteins#877097ClinicalTrials.gov
• Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis#136369ClinicalTrials.gov
• Psychological well-being in adults with cystic fibrosis during pregnancy and parenthood: A systematic review#450727ULRR
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older#825005ClinicalTrials.gov
• The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis#828931ClinicalTrials.gov
• Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation#834593ClinicalTrials.gov
• The Relationship Between Diet and Glycemic Response and Inflammatory Markers in Children With Cystic Fibrosis#853729ClinicalTrials.gov
• The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis#968329ClinicalTrials.gov
• Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease#980827ClinicalTrials.gov
• 3D Automated Segmentation of Bronchial Abnormalities on Ultrashort Echo Time MRI : A Quantitative MR Outcome in Cystic Fibrosis#194407HAL (France)
• Mechanistic Insights into Cystic Fibrosis Transmembrane Conductance Regulator Function from Molecular Dynamics Analysis of Electrostatic Interactions#367459HAL (France)
• The iStep Study: Development and Validation of an Incremental Exercise Step Test for Children With Cystic Fibrosis#892695ClinicalTrials.gov
• Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes#141192ClinicalTrials.gov
• Effects of a Partially Supervised Conditioning Program in CF#668937ClinicalTrials.gov
• A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation#841712ClinicalTrials.gov
• Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis#844679ClinicalTrials.gov
• Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation#915072ClinicalTrials.gov
• Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis#833264ClinicalTrials.gov
• Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls.#856870ClinicalTrials.gov
• Exercise Capacity, Muscle Oxygenation, Respiratory Muscle Strength, and Physical Activity Level in Pediatric CF and PCD#860158ClinicalTrials.gov
• A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele#914128ClinicalTrials.gov
• Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex#628558ClinicalTrials.gov
• Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis#703581PhilArchive
• Feasibility of Cough Monitoring in Children#854185ClinicalTrials.gov
• Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis#908110ClinicalTrials.gov
• Obstetric and neonatal outcomes in pregnancies from a dedicated cystic fibrosis-maternal health service: a retrospective study#393587Spiral
• Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function#894992ClinicalTrials.gov
• Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials#904202ClinicalTrials.gov